Currently the editor of "The Biotech Forum," Bret Jensen was chief investment strategist for Simplified Asset Management (S.A.M.), a small long/short hedge fund based in Miami, from 2008-2011. The fund was in the top 5% of long/short hedge funds for total return in its first full year (2009), as ranked by Hedgeco fund database (more than 450 funds in category). Prior to this, he spent a decade as technology director of a Fortune 100 firm.Expand

Jensen has been a top-5%-ranked financial analyst and blogger since 2013, according to TipRanks. He holds a Bachelor of Science degree in finance from Arizona State University.

Follow Bret on Twitter: @Bret_Jensen.Collapse

The credit card provider and the biotech concern appear cheap relative to their potential.
The domestic economy is performing at a level unseen in almost 2 decades.
These boring, low-beta income plays would be a great addition to any income seeker's portfolio.
Both biotech stocks are at or near 52-week lows, but don't deserve to be.
Lannett Co. and Builders FirstSource have seen insiders make purchases at recent low valuations.
These 5 stocks are a good value on this weakness.
Progenics and Tesaro are among sagging small-cap biotech stocks that could rebound in coming months.
.We haven't seen these type of earnings gains since 2010
They are LGI Homes, Beazer Homes, Prestige Consumer Healthcare, Gulfport Energy and Cabot Oil.
You may have missed this, but the U.S. economy is humming.

Columnist Conversations

View Chart »  View in New Window » I did a twitter video on this one yesterday.  I...
Amazon (AMZN) has the 20 DMA @ 1958 above. It can certain trade lower as it has made lower weekly highs and lo...
Tilray's staggering 41% rise this morning leaves the company with an insane valuation and leaves Canopy Growth...
I badly want to be the person that calls the top in red-hot cannabis stocks, but fear looking like a short-ter...

BEST IDEAS

News Breaks

Powered by

COLUMNIST TWEETS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.